Decreased permeability and enhanced proton-dependent active efflux in the development of resistance to quinolones in Morganella morganii

International Journal of Antimicrobial Agents

Volumn 14, Issue 2, 2000, Pages 157-160

  Del Mar Tavío, María ^a   Vila, Jordi ^b   Ruiz, Joaquím ^b   Manuel Martín Sánchez, Antonio ^a   Teresa Jiménez De Anta, María ^b  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Active efflux; Morganella morganii; Permeability; Quinolones; Resistance

Indexed keywords

ACRIFLAVINE; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CHLORAMPHENICOL; CIPROFLOXACIN; LOMEFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TEMAFLOXACIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; CELL MEMBRANE PERMEABILITY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; MUTATION; PHENOTYPE; PRIORITY JOURNAL; STRAIN DIFFERENCE;

4-QUINOLONES; ANTI-INFECTIVE AGENTS; BIOLOGICAL TRANSPORT, ACTIVE; CELL MEMBRANE PERMEABILITY; DRUG RESISTANCE, MICROBIAL; MICROBIAL SENSITIVITY TESTS; MORGANELLA MORGANII; MUTATION; PROTONS;

EID: 0034099126     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00117-5     Document Type: Article

References (13)

1. Mitsuyama J., Hiruma R., Yamaguchi A., Sawai T. Identification of porins in outer membrane of Proteus, Morganella and Providencia spp. and their role in outer membrane permeation of β-lactams. Antimicrob. Agents Chemother. 31:1987;379-384.
2. Vila J., Ruiz J., Marco F. et al. Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs. Antimicrob. Agents Chemother. 38:1994;2477-2479.
3. Vila J., Ruiz J., Goñi P., Jiménez de Anta M.T. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 40:1996;491-493.
4. Tavío MM, Vila J, Ruiz J, Ruiz J, Martín-Sánchez AM, Jiménez de Anta MT. Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates, J Antimicrob Chemother 1999;44 (in press).
5. Ishii H., Sato K., Hoshino K. et al. Active efflux of ofloxacin by a highly quinolone-resistant strain of Proteus vulgaris. J. Antimicrob. Chemother. 28:1991;827-836.
6. Ishida H., Fuziwara H., Kaibori Y., Horiuchi T., Sato K., Osada Y. Cloning of multidrug resistance gene pqrA from Proteus vulgaris. Antimicrob. Agents Chemother. 39:1995;453-457.
7. Hooper D.C., Wolfson J.S., Souza K.S., Tung C., McHugh G.L., Swartz M.N. Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli. Antimicrob. Agents Chemother. 29:1986;639-644.
8. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A2. National Committe for Clinical Laboratory Standards, Villanova, Pa, 1996.
9. Sawai T., Hiruma R., Kawana N., Kaneko M., Taniyasu F., Inami A. Outer membrane permeation of β-lactam antibiotics in Escherichia coli, Proteus mirabilis, and Enterobacter cloacae. Antimicrob. Agents Chemother. 22:1982;585-592.
10. Hitchcock P.J., Brown T.M. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J. Bacteriol. 154:1983;269-277.
11. Peterson A.A., McGroarty E.J. High-molecular-weight components in lipopolysaccharides of Salmonella typhimurium, Salmonella minnesota, and Escherichia coli. J. Bacteriol. 162:1985;738-745.
12. Alekshun M.N., Levy S.B. Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob. Agents Chemother. 41:1997;2067-2075.
13. Oethinger M., Podglajen I., Kern W.V., Levy S.B. Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli. Antimicrob. Agents Chemother. 42:1998;2089-2094.